Navigation Links
First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
Date:4/2/2013

Reno, Nev. (PRWEB) April 02, 2013

First Warning Systems (FWS), Inc., a pioneer and developer of early breast cancer detection, announced the appointment of Rob Royea as the company’s new chief executive officer (CEO). Royea has over 25 years of proven senior executive experience in the creation and execution of strategic visions to grow sophisticated medical technology, diagnostic and software companies. He has successfully led efforts of both public and private venture capital backed technology companies with worldwide operations.

“We are excited to have Rob lead our efforts in finalizing our go-to-market commercialization strategies,” said Jim Holmes, chairman of the board for FWS. “He will also spearhead the closing of our current $1.2 million funding round followed by our Series A financing for $10 million. I look forward to working with Rob in these endeavors.”

Royea has significant expertise in global medical operations. His experience includes demonstrated profit and loss responsibilities from startup companies to those with more than $550 million in revenues. He has successfully directed the acquisition and sale of several companies over the past 36 months. He has managed direct to market and distribution strategies in Japan, India; Europe, the Middle East, Africa (EMEA); and the United States for companies with as many as 400 employees. He has successfully created and implemented business plans to launch two technologies achieving the number one market position globally for each.

Royea will head a growing organization dedicated to early breast cancer detection. The FWS process uses a non-irradiative, non-compressive method to create a dynamic cell chaos profile correlated to dysfunctional circadian genes. Multiple bioinformatics algorithms compare the circadian gene protein profiles to identify breast tissue abnormalities at early stages of development of disturbed breast cancerous cells.

“With the surge of states requiring physicians to notify patients that they have dense breast tissue, a solution must evolve to address this at-risk patient population,” said Royea. “This condition is more difficult to interpret with standard imaging alternatives and is associated with higher risk for breast cancer. FWS has now completed five years of research and development to ensure accurate, reproducible outcomes for breast cancer screening, focusing on mitotic cellular activity and proteomics. As this solution can work on any age and any tissue type, the FWS solution can create significant health management value for women worldwide while providing a protocol for clinicians to manage early onset situations.”

According to Royea, analysts indicate the worldwide value in the marketplace exceeds $3 billion. Holmes, who has been acting as CEO, will return to his CFO position and remain chairman of the board.

About First Warning Systems

First Warning Systems (FWS), founded in 2008, is based in Reno, Nevada. FWS’s principal shareholder is Lifeline Biotechnologies, Inc. (OTC Market: LLBO). FWS holds the exclusive development, manufacturing and marketing worldwide license from Lifeline to commercialize its intellectual property. The FWS product line is a device and process that detects breast tissue abnormalities leading to health risk assessment and management and, potentially, breast cancer. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. FWS is preparing to apply for a European CE Mark to market in the UK, EU and Russia markets. See FWS’ video, “Breast Cancer Tumor Progression,” at http://www.firstwarningsystems.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10591157.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
2. First Time in Philadelphia Is a Success for Pittcon 2013 (Summary Report)
3. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
4. Medifirst Solutions, Inc. Announces Further Update To Shareholders
5. BioMed Realty Trust Declares First Quarter 2013 Common Stock Dividend
6. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
7. First-To-File Patent Law Is Now In Effect, But What Does it Mean?
8. First Southeast Venture Philanthropy Summit Set In NC
9. Rigaku Raman Unveils Upgraded FirstGuard Handheld Analyzer with Industry’s Only 1064nm Wavelength Capabilities
10. First 3D Heads-Up Cataract Surgery Performed in Asia
11. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former ... of the University of North Carolina Kenan-Flagler Business School effective June ... UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes and ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
Breaking Biology News(10 mins):